All Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TX
Published September 3, 2014 · Recall initiated: December 19, 2013
Summary
FDA records drug Class II recall D-1564-2014, published September 3, 2014 and initiated December 19, 2013. Recalling firm: Abrams Royal Pharamacy; Status: Terminated; Reported quantity: N/A; Lot: All unexpired lots of sterile drug products. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abrams Royal Pharamacy
- Distributor
- Nationwide and to Canada
- Lot
- All unexpired lots of sterile drug products
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TXSeptember 3, 2014
- FDAMidazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Pharmakon Pharmaceuticals, Inc.,September 3, 2014
- FDALOW Potassium Cardioplegia 792 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150September 3, 2014
- FDAMidazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bag, Rx Only. Labeled A) 50 mL, PharmakonSeptember 3, 2014
- FDAadenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MISeptember 3, 2014
- FDAGlycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd.,September 3, 2014
Questions about this recall
Was All Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TX recalled?
Yes. FDA published recall D-1564-2014 on September 3, 2014. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter